Literature DB >> 12577308

Characterization of the neuropilin-1 promoter; gene expression is mediated by the transcription factor Sp1.

Mireille Rossignol1, Jacques Pouysségur, Michael Klagsbrun.   

Abstract

Neuropilin-1 (NRP1) is a receptor for the vascular endothelial growth factor (VEGF) family of angiogenesis factors and for the semaphorin family of secreted neuronal guidance polypeptides. Very little is known, however, about how NRP1 gene expression is regulated. In this study, it was demonstrated that the tumor promoter, TPA (12-O-tetradecanoylphorbol-13-acetate) significantly up-regulated NRP1 mRNA levels by increasing its gene transcription rate in a manner dependent on de novo protein synthesis. To determine which elements regulate functional NRP1 expression, the promoter regions of human and mouse NRP1 genes were cloned and characterized. Promoter-reporter gene transfection experiments using deletion and point mutations demonstrated that two Sp1 elements are major contributors to both the constitutive and TPA-induced activity of the NRP1 promoter. Gel shift analysis showed a specific binding of the Sp1 transcription factor to those elements. Further mutational analysis revealed that an AP-1, and a CCAAT box also contributed to NRP1 constitutive and TPA-induced promoter activity. It was concluded that NRP1 expression is regulated by the cooperation of several regulatory elements including AP-1, Sp1, and a CCAAT box. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12577308     DOI: 10.1002/jcb.10384

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  14 in total

1.  Neuropilin-1 is a direct target of the transcription factor E2F1 during cerebral ischemia-induced neuronal death in vivo.

Authors:  Susan X Jiang; Melissa Sheldrick; Angele Desbois; Jacqueline Slinn; Sheng T Hou
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

Review 2.  Advances in distinguishing natural from induced Foxp3(+) regulatory T cells.

Authors:  Xiaohong Lin; Maogen Chen; Ya Liu; Zhiyong Guo; Xiaoshun He; David Brand; Song Guo Zheng
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

3.  A system view and analysis of essential hypertension.

Authors:  Alon Botzer; Ehud Grossman; John Moult; Ron Unger
Journal:  J Hypertens       Date:  2018-05       Impact factor: 4.844

4.  An exquisite cross-control mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cells.

Authors:  Jinjoo Kang; Jaehyuk Yoo; Sunju Lee; Wanli Tang; Berenice Aguilar; Swapnika Ramu; Inho Choi; Hasan H Otu; Jay W Shin; G Paolo Dotto; Chester J Koh; Michael Detmar; Young-Kwon Hong
Journal:  Blood       Date:  2010-03-29       Impact factor: 22.113

5.  Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells.

Authors:  Sirin A I Adham; Ifat Sher; Brenda L Coomber
Journal:  Lab Invest       Date:  2010-03-01       Impact factor: 5.662

6.  Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation.

Authors:  Danny C W Yu; Jennifer S Waby; Haridasan Chirakkal; Carolyn A Staton; Bernard M Corfe
Journal:  Mol Cancer       Date:  2010-10-15       Impact factor: 27.401

7.  Identification of two novel alternatively spliced Neuropilin-1 isoforms.

Authors:  Frank C Cackowski; Li Xu; Bo Hu; Shi-Yuan Cheng
Journal:  Genomics       Date:  2004-07       Impact factor: 5.736

8.  Clinical significance of expanded Foxp3⁺ Helios⁻ regulatory T cells in patients with non-small cell lung cancer.

Authors:  Satoshi Muto; Yuki Owada; Takuya Inoue; Yuzuru Watanabe; Takumi Yamaura; Mitsuro Fukuhara; Naoyuki Okabe; Yuki Matsumura; Takeo Hasegawa; Jun Osugi; Mika Hoshino; Mitsunori Higuchi; Hiroyuki Suzuki; Mitsukazu Gotoh
Journal:  Int J Oncol       Date:  2015-10-12       Impact factor: 5.650

Review 9.  Role of Neuropilin-1 in Diabetic Nephropathy.

Authors:  Tzvetanka Bondeva; Gunter Wolf
Journal:  J Clin Med       Date:  2015-06-17       Impact factor: 4.241

10.  MicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expression.

Authors:  Yang Peng; Yan-Min Liu; Lu-Chun Li; Lu-Lu Wang; Xiao-Ling Wu
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.